Cytiva is a global provider of technologies and services that support the development and manufacture of therapeutics. The company specializes in bioprocessing, offering a range of products and solutions designed to enhance the efficiency and effectiveness of biopharmaceutical production. Cytiva's portfolio includes equipment, consumables, and software that are utilized in various stages of the biomanufacturing process.
Founded as part of GE Healthcare, Cytiva has established itself as a key player in the life sciences sector. The company focuses on enabling customers to accelerate their research and development efforts, ultimately contributing to the advancement of healthcare solutions. With a commitment to innovation, Cytiva invests in research and development to provide cutting-edge technologies that meet the evolving needs of the biopharmaceutical industry.
Cytiva operates globally, serving a diverse clientele that includes biotechnology companies, pharmaceutical manufacturers, and academic institutions. The company emphasizes collaboration and partnerships to drive progress in bioprocessing and improve patient outcomes through more efficient drug development and production processes.




